Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 12Dr. Reddy's Laboratories
03 4Breckenridge Pharmaceutical
04 4Ever Pharma
05 17Accord healthcare
06 4Anabiosis S.A.
07 8Apotex Inc
08 4Aurobindo Pharma Limited
09 4Avansor Pharma Oy
10 4BASI
11 3Bioglan
12 4Bristol Laboratories Ltd
13 27Bristol Myers Squibb
14 4Celgene Corporation
15 4Cipla Medpro South Africa
16 8Day Zero Ehf
17 4Deva Holding AS
18 2Eurolab
19 2Farmoz Sociedade Tecnico Medicinal Sa
20 4GSK
21 4Greendex AS
22 8Grindeks AS
23 4Hetero Drugs
24 4JAMP PHARMA
25 16Juno Pharmaceuticals Pty Ltd
26 4Key Oncologics
27 8Krka
28 4Laboratorio Eczane Pharma
29 4Natco Pharma (Canada) Inc
30 4Newbury Pharmaceuticals AB
31 4Newbury Pharmaceuticals Ab
32 4Pinnacle Life Science
33 2Reig Jofre
34 8STADA Arzneimittel
35 1Sakar Healthcare
36 32Sandoz B2B
37 4Spirig Healthcare
38 4Tecnimede
39 22Teva Pharmaceutical Industries
40 19Viatris
41 4XYZ Pharma
42 8Zentiva
01 10CAP
02 24CAPSULE
03 32CAPSULE;ORAL
04 113Capsule
05 5Capsules
06 64Hard Capsule
07 4Oral Solid Dosage Form
08 1Pomalidomide 1Mg 21 Combined Oral Use
09 1Pomalidomide 2Mg 21 Combined Oral Use
10 1Pomalidomide 3Mg 21 Combined Oral Use
11 1Pomalidomide 4Mg 21 Combined Oral Use
12 12capsule
13 31Blank
01 32Allowed
02 67Approved
03 32Authorized
04 24DISCN
05 6Generic
06 4Lead Market Dossiers- Filed
07 4Lead Market Dossiers- Tentative\nApproved in US
08 28Marketed
09 4Not Marketed
10 4Originator
11 24Prescription
12 4RX
13 66Blank
01 4APO-POMALIDOMIDE
02 4Davunfite
03 19Imnovid
04 1Imnovid 1 mg
05 1Imnovid 2 mg
06 1Imnovid 3 mg
07 1Imnovid 4 mg
08 4JAMP POMALIDOMIDE
09 4NAT-POMALIDOMIDE
10 28POMALIDOMIDE
11 8POMALYST
12 4Pomalidomid Avansor
13 4Pomalidomid Devatis
14 4Pomalidomida Accord
15 4Pomalidomida Eczane
16 4Pomalidomida Erawya
17 4Pomalidomida Krka
18 2Pomalidomida Sala
19 4Pomalidomida Stada
20 2Pomalidomida Teva
21 4Pomalidomide
22 1Pomalidomide 1 mg Cipla
23 1Pomalidomide 2 mg Cipla
24 1Pomalidomide 3 mg Cipla
25 1Pomalidomide 4 mg Cipla
26 13Pomalidomide Accord
27 4Pomalidomide Anabiosis
28 3Pomalidomide Bioglan
29 4Pomalidomide Ever Pharma
30 4Pomalidomide Glenmark
31 4Pomalidomide Grindeks
32 4Pomalidomide Krka
33 8Pomalidomide Newbury
34 28Pomalidomide Sandoz
35 4Pomalidomide Spirig HC
36 4Pomalidomide Stada
37 2Pomalidomide Tecnogen
38 8Pomalidomide Teva
39 15Pomalidomide Viatris
40 12Pomalidomide Zentiva
41 4Pomalidomide-Teva
42 4Pomalidomide-Teva Mepha
43 8Pomalyst
44 1Pomaxel 3 mg
45 1Pomaxel 4 mg
46 16Pomolide
47 4REDDY-POMALIDOMIDE
48 4SANDOZ POMALIDOMIDE
49 4Sulabcote
50 21Blank
01 4Argentina
02 36Australia
03 24Canada
04 13India
05 4Italy
06 8Latvia
07 1Moldova
08 32Norway
09 4Portugal
10 10South Africa
11 32Spain
12 67Sweden
13 32Switzerland
14 32USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 1mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Pomalidomide Ever Pharma
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 18/12/2024
Application Number : 20230928000125
Regulatory Info : Approved
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 2mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 3mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Pomalidomide Zentiva
Dosage Form : Hard Capsule
Dosage Strength : 4mg
Packaging :
Approval Date : 03/06/2024
Application Number : 69057
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 2504073
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 2504081
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 2504103
Regulatory Info : Prescription
Registration Country : Canada
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : REDDY-POMALIDOMIDE
Dosage Form : CAPSULE
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2504111
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
